LAUREN KARENBAUER
Physician Assistants & Advanced Practice Nursing Providers|Physician Assistant|Medical GETTYSBURG, PA NPI 1740060003
Browse related groups: Physician Assistants & Advanced Practice Nursing Providers|Physician Assistant|Medical PA Tempus AI, Inc All categories
General Payments — all program years on this page
$1,547.75
- Category: General Payments
- Program years: PY2023–2024
- Record count: 72
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $1,532.97 across 71 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,532.97 | 71 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Tempus AI, Inc | $173.42 | 5 |
| Acerta Pharma LLC | $158.10 | 8 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $140.60 | 7 |
| Daiichi Sankyo Inc. | $136.47 | 9 |
| Janssen Biotech, Inc. | $117.57 | 5 |
| Astellas Pharma US Inc | $104.61 | 5 |
| Bayer HealthCare Pharmaceuticals Inc. | $85.34 | 4 |
| Incyte Corporation | $68.68 | 3 |
| Celgene Corporation | $66.66 | 3 |
| GENZYME CORPORATION | $64.37 | 2 |
| ABBVIE INC. | $51.25 | 2 |
| Merck Sharp & Dohme Corporation | $42.87 | 2 |
| PFIZER INC. | $35.75 | 2 |
| Immunocore Limited | $24.49 | 1 |
| EMD Serono, Inc. | $23.68 | 1 |
| PUMA BIOTECHNOLOGY, INC. | $23.35 | 1 |
| Gilead Sciences, Inc. | $22.68 | 1 |
| PharmaEssentia USA Corporation | $22.58 | 1 |
| Regeneron Healthcare Solutions, Inc. | $22.27 | 1 |
| BeiGene USA, Inc. | $22.07 | 1 |
| SOBI, INC | $22.00 | 1 |
| Genentech USA, Inc. | $20.00 | 1 |
| E.R. Squibb & Sons, L.L.C. | $18.48 | 1 |
| ARRAY BIOPHARMA INC | $18.09 | 1 |
| EISAI INC. | $17.63 | 1 |
| Alexion Pharmaceuticals, Inc. | $17.49 | 1 |
| Rigel Pharmaceuticals, Inc. | $12.47 | 1 |
By program year
Records — PY2024 (71)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.